For Investors

Building financial infrastructure for aesthetic medicine.

MelanCare is developing a B2B2C InsurTech model designed to connect aesthetic practices, patients and insurance partners around financial protection for selected aesthetic treatments involving melanated skin.

The problem

  • 01Patients can face significant out-of-pocket exposure around selected aesthetic treatments.
  • 02MedSpas need differentiated ways to build confidence and trust throughout the patient journey.
  • 03Existing financial protection models may not be designed specifically around this aesthetic medicine use case.
  • 04MelanCare is exploring a specialized model built around the intersection of aesthetic medicine, financial protection and melanated skin.

The solution

MelanCare is designed as a B2B2C platform integrated into the MedSpa checkout experience.

Distribution

MedSpa

MelanCare

Patient

Risk

MelanCare

Insurance partner

The insurance partner would carry the underlying risk.

Business model

The final commercial structure is being developed together with the insurance ecosystem. The model currently being explored combines four components.

01

MedSpa distribution

02

Patient protection purchase

03

Insurance partner

04

MelanCare technology / distribution / infrastructure

Business model subject to product, regulatory and carrier structure.

Investor FAQ

Interested in learning more about MelanCare?

We are happy to share more about the company, the product being developed and the current stage.

investors@melancare.com

Investor inquiry

Submitting opens a pre-filled email to investors@melancare.com; no data is stored on this website.